文献速递妇科产科

大型人群队列研究中子宫内膜癌幸存者的长期不良泌尿生殖结局

Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study.
PubMed 文献 · Gynecol Oncol · 2017-12-27

该研究纳入1997至2012年犹他州2648例子宫内膜癌幸存者与10503例一般人群女性,采用多因素Cox回归评估诊断后1-5年及>5-10年泌尿生殖结局风险。子宫内膜癌幸存者泌尿系统疾病和生殖器官疾病风险在两个时间段均升高,肾衰竭、慢性肾脏病、尿路感染及乳腺良性病变风险在>5-10年持续升高。作者认为该证据提示需加强对子宫内膜癌患者泌尿生殖疾病的监测和咨询。

要点

  • 子宫内膜癌幸存者诊断后1-5年及>5-10年泌尿系统疾病风险均升高。
  • 生殖器官疾病风险在1-5年及>5-10年两个时间段均升高。
  • 肾衰竭、慢性肾脏病、尿路感染及乳腺良性病变风险在>5-10年持续升高。

核心结论

  • 与一般人群女性相比,子宫内膜癌幸存者多种泌尿生殖结局风险更高。
  • 该研究提供证据提示,对子宫内膜癌患者在治疗结束后即刻及此后数年加强泌尿生殖疾病监测和咨询具有必要性。

研究设计与样本

  • 大型人群队列研究,纳入1997至2012年犹他州诊断的2648例子宫内膜癌幸存者与10503例一般人群女性。
  • 从该州两个最大医疗系统及全州数据库收集所有ICD-9诊断编码。
  • 采用多因素Cox回归模型估计子宫内膜癌诊断后1-5年及>5-10年泌尿生殖结局的风险比。

主要发现

  • 子宫内膜癌幸存者1-5年泌尿系统疾病风险升高(HR 1.64,95% CI 1.50-1.78),>5-10年仍升高(HR 1.40,95% CI 1.26-1.56)。
  • 子宫内膜癌幸存者1-5年生殖器官疾病风险升高(HR 1.71,95% CI 1.58-2.03),>5-10年仍升高(HR 1.33,95% CI 1.19-1.49)。
  • 子宫内膜癌幸存者肾衰竭、慢性肾脏病、尿路感染及乳腺良性病变风险显著升高,且在>5-10年持续存在。
  • 癌症诊断后1-5年,分期更高、分级更高、年龄更大及接受放疗或化疗者泌尿系统疾病风险更高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: With the increasing incidence of endometrial cancer, the high survival rate, and the large number of endometrial cancer survivors, investigations of long-term genitourinary outcomes are important for the management of these outcomes among endometrial cancer survivors. METHODS: Cohorts of 2648 endometrial cancer survivors diagnosed in the state of Utah between 1997 and 2012 and 10,503 general population women were identified. All ICD-9 diagnosis codes were collected from the state's two largest healthcare systems and statewide databases. Multivariate Cox regression models were used to estimate hazard ratios at 1-5years and >5-10years after endometrial cancer diagnosis for genitourinary outcomes. RESULTS: Endometrial cancer survivors were at elevated risk for urinary system disorders between 1 and 5years (HR: 1.64, 95% CI: 1.50-1.78) and >5-10years (HR: 1.40, 95% CI: 1.26-1.56) and genital organ disorders between 1 and 5years (HR: 1.71, 95% CI: 1.58-2.03) and >5-10years (HR: 1.33, 95% CI: 1.19-1.49). Significantly elevated risk was observed among endometrial cancer survivors for renal failure, chronic kidney disease, urinary tract infections, and nonmalignant breast conditions, persisting between >5-10years. Between 1 and 5years after cancer diagnosis, those with higher stage, higher grade, older age and treated with radiation or chemotherapy were at higher risk for urinary disorders. CONCLUSIONS: Endometrial cancer survivors were at higher risk for many genitourinary outcomes compared to women from the general population. This study presents evidence suggesting the necessity of increased monitoring and counseling for genitourinary disorders for endometrial cancer patients both immediately after treatment cessation and for years afterwards.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Soisson S, Ganz PA, Gaffney D, et al. Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study. Gynecol Oncol. 2017. PMID: 29289418. doi:10.1016/j.ygyno.2017.12.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。